TWI779251B - Use of a plant extraction for enhancing the gene expression of cct, atg, nadsyn, mrps5, sod3, and tert and/or increase the amount of gsh - Google Patents
Use of a plant extraction for enhancing the gene expression of cct, atg, nadsyn, mrps5, sod3, and tert and/or increase the amount of gsh Download PDFInfo
- Publication number
- TWI779251B TWI779251B TW108142378A TW108142378A TWI779251B TW I779251 B TWI779251 B TW I779251B TW 108142378 A TW108142378 A TW 108142378A TW 108142378 A TW108142378 A TW 108142378A TW I779251 B TWI779251 B TW I779251B
- Authority
- TW
- Taiwan
- Prior art keywords
- gene
- extract
- present
- cells
- expression
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Botany (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Cosmetics (AREA)
Abstract
Description
本發明係關於一種植物萃取物用於提升CCT基因、Atg基因、NADSYN基因、MRPS5基因、SOD3基因、及TERT基因表現量與提升GSH含量的用途之用途,尤其是一種係為一天山雪蓮萃取物、一龍眼殼萃物、一蕎麥萃取物、及其任意組合所組成之植物萃取物用於製備提升CCT2基因、CCT7基因、CCT8基因、Atg1基因、Atg8基因、NADSYN基因、MRPS5基因、SOD3基因、及TERT基因表現量,及/或提升GSH的含量之組合物的用途。 The present invention relates to the use of a plant extract for increasing the expression of CCT gene, Atg gene, NADSYN gene, MRPS5 gene, SOD3 gene, and TERT gene and increasing the GSH content, especially a kind of extract from Snow Lotus of Tiantian Mountain , a longan shell extract, a buckwheat extract, and a plant extract composed of any combination thereof are used to prepare CCT2 gene, CCT7 gene, CCT8 gene, Atg1 gene, Atg8 gene, NADSYN gene, MRPS5 gene, SOD3 gene, And TERT gene expression level, and/or the use of the composition for increasing the content of GSH.
在生物學及醫學上,老化(aging)是指一個生物體之生理狀態隨時間而惡化的現象,老化會造成身體各部分組織或器官機能衰退或功能減弱,使得生物體的健康功能變差,最後導致生物體死亡,現代人生活壓力大,長期壓力的累積會加速身體機能老化,也衍生出許多慢性疾病。 In biology and medicine, aging refers to the phenomenon that the physiological state of an organism deteriorates over time. Aging will cause the decline or weakening of the functions of tissues or organs in various parts of the body, making the health of the organism worse. Ultimately, it leads to the death of organisms. Modern people live under high pressure. The accumulation of long-term stress will accelerate the aging of body functions and lead to many chronic diseases.
另外,隨著保健意識的抬頭及醫療技術的進步,人均壽命增長,但老化所造成的機能退化依然伴隨年齡的增長而加劇,因此除了在疾病的治療及預防外,老化的預防也是高齡社會的重要課題之一。 In addition, with the rise of health care awareness and the advancement of medical technology, the average life expectancy increases, but the functional degradation caused by aging is still intensified with age. Therefore, in addition to the treatment and prevention of diseases, the prevention of aging is also an important aspect of the aging society. one of the important subjects.
雖然目前已研究出許多與老化相關的基因以及相關的機制,但是目前仍然沒有能有效應用於延緩老化的藥物或方法,大多只能建議從飲食上多攝取具抗氧化活性物質的食物,並維持適當運動與保持正常作息及心情愉悅。 Although many genes and related mechanisms related to aging have been studied, there are still no drugs or methods that can be effectively applied to delay aging. Proper exercise and maintain a normal work and rest and a happy mood.
綜上所述,為了能方便又有效達到延緩老化的功效,開發一種能有效提升抗老化基因表現量、及抗氧化力的組合物,著實有其必要性。 To sum up, in order to achieve the anti-aging effect conveniently and effectively, it is necessary to develop a composition that can effectively increase the expression level of anti-aging genes and the antioxidant capacity.
緣此,本發明之一目的在提供一種植物萃取物用於製備提升含TCP1的折疊蛋白(Chaperonin containing TCP1,CCT)基因、自噬作用相關基因(Autophagy-related gene,Atg)基因、麩醯胺酸依賴性菸草醯胺腺嘌呤二核苷酸合成酶(Glutamine-dependent NAD+ synthetase,NADSYN)基因、粒線體核糖體蛋白5(mitochondrial ribosomal protein S5,MRPS5)基因、超氧化物歧化酶3(Superoxide dismutase 3,SOD3)基因、及端粒酶反轉錄酶(Telomerase reverse transcriptase,TERT)基因表現量之組合物的用途;其中該植物萃取物係由一天山雪蓮萃取物、一龍眼殼萃取物、一蕎麥萃取物、及其任意組合所組成。
For this reason, one object of the present invention is to provide a kind of plant extract to be used for preparing and promoting the folder protein (Chaperonin containing TCP1, CCT ) gene containing TCP1, autophagy-related gene (Autophagy-related gene, Atg ) gene, glutamine Acid-dependent tobacco amide adenine dinucleotide synthetase (Glutamine-dependent NAD + synthetase, NADSYN ) gene, mitochondrial ribosomal protein 5 (mitochondrial ribosomal protein S5, MRPS5 ) gene, superoxide dismutase 3 ( Superoxide
本發明之另一目的在提供一種植物萃取物用於製備提升榖胱甘肽(Glutathione,GSH)含量之組合物的用途,其中該植物萃取物係由一天山雪蓮萃取物、一龍眼殼萃取物、一蕎麥萃取物、及其任意組合所組成。 Another object of the present invention is to provide a plant extract for the preparation of a composition for increasing glutathione (Glutathione, GSH) content, wherein the plant extract is composed of Tianshan Snow Lotus extract, a longan shell extract , a buckwheat extract, and any combination thereof.
在本發明之一實施例中,該CCT基因係含TCP1第2次單元的折疊蛋白(Chaperonin containing TCP1 subunit2,CCT2)基因、含TCP1第7次單元的折疊蛋白(Chaperonin containing TCP1 subunit 7,CCT7)基因、含TCP1第8次單元的折疊蛋白(Chaperonin containing TCP1 subunit 8,CCT8)基因、及其任意組合;且該Atg基因係自噬作用相關基因1(Autophagy-related gene 1,Atg1)基因、自噬作用相關基因8(Autophagy-related gene 8,Atg8)基因或其組合。
In one embodiment of the present invention, the CCT gene is a chaperonin containing TCP1 subunit 2 (CCT2) gene, a chaperonin containing TCP1 subunit 7 ( CCT7 ) gene, and a chaperonin containing TCP1 subunit 7 ( CCT7 ) gene. gene, the folding protein (Chaperonin containing TCP1 subunit 8, CCT8 ) gene containing the 8th unit of TCP1, and any combination thereof; and the Atg gene is an autophagy-related gene 1 (Autophagy-
在本發明之又一實施例中,該植物萃取物係增加抗老化活性。 In yet another embodiment of the present invention, the plant extract increases anti-aging activity.
在本發明之又一實施例中,該植物萃取物係調節一細胞之調節NAD+濃度、及/或端粒長度。 In yet another embodiment of the present invention, the plant extract modulates NAD + concentration, and/or telomere length of a cell.
在本發明之又一實施例中,該植物萃取物係增加抗氧化活性。 In yet another embodiment of the present invention, the plant extract increases antioxidant activity.
在本發明之又一實施例中,該植物萃取物係以一溶劑進行萃取,該溶劑為水、醇、或醇水混合物。 In yet another embodiment of the present invention, the plant extract is extracted with a solvent, and the solvent is water, alcohol, or a mixture of alcohol and water.
在本發明之又一實施例中,該植物萃取物的濃度為至少0.5%(v/v)。 In yet another embodiment of the present invention, the concentration of the plant extract is at least 0.5% (v/v).
在本發明之另一實施例中,該植物萃取物係該天山雪蓮萃取物、該龍眼殼萃取物、該一蕎麥萃取物以2.4-3.6:129.6-194.4:128.8-193.2比例混合所組成。 In another embodiment of the present invention, the plant extract is composed of the Tianshan Snow Lotus extract, the longan shell extract, and the buckwheat extract in a ratio of 2.4-3.6:129.6-194.4:128.8-193.2.
本發明之植物萃取物係為一天山雪蓮萃取物、一龍眼殼萃取物、一蕎麥萃取物、及其任意組合所組成;該天山雪蓮萃取物、該龍眼殼萃取物、及該蕎麥萃取物皆能有效提升血球細胞、皮膚細胞、心血管細胞、及/或視網膜細胞中與粒線體或細胞抗老化相關之基因的表現量,且該三種萃取物特別對心血管細胞有顯著的抗老化功效。而該三種萃取物的組合亦能夠直接且有效的提升CCT2基因、CCT7基因、CCT8基因、Atg1基因、Atg8基因、NADSYN基因、MRPS5基因、SOD3基因、及TERT基因的表現量,能夠全面的提升的抗老化活性,且本發明之植物萃取物能同時提升GSH的含量,以全面的提升體內的抗氧化活性;本發明之植物萃取物能有效促進體內反轉回青春有活力的狀態。因此,本發明之植物萃取物可用於製備抗老化之組合物的用途,其中該組合物是一醫藥品、一食品或一保養品,可藉由口服、皮膚塗抹等方式給予一個體。 The plant extract of the present invention is composed of Tianshan Snow Lotus extract, a longan shell extract, a buckwheat extract, and any combination thereof; the Tianshan Snow Lotus extract, the longan shell extract, and the buckwheat extract are all Can effectively increase the expression of genes related to mitochondrial or cell anti-aging in blood cells, skin cells, cardiovascular cells, and/or retinal cells, and the three extracts have a significant anti-aging effect on cardiovascular cells . The combination of these three extracts can also directly and effectively increase the expression of CCT2 gene, CCT7 gene, CCT8 gene, Atg1 gene, Atg8 gene, NADSYN gene, MRPS5 gene, SOD3 gene, and TERT gene, and can comprehensively improve the Anti-aging activity, and the plant extract of the present invention can increase the content of GSH at the same time, so as to comprehensively enhance the antioxidant activity in the body; the plant extract of the present invention can effectively promote the body to return to a youthful and energetic state. Therefore, the plant extract of the present invention can be used to prepare an anti-aging composition, wherein the composition is a medicine, a food or a skin care product, and can be administered to an individual by oral administration or skin application.
圖1係為本發明之一實施例的天山雪蓮萃取物提升血球細胞中CCT2基因、CCT5基因、及CCT6A基因表現量之效果的長條圖。* p值<0.05。 Fig. 1 is a bar graph showing the effect of Saussurea tianshanensis extract on enhancing the expression of CCT2 gene, CCT5 gene, and CCT6A gene in blood cells according to one embodiment of the present invention. *p-value <0.05.
圖2係為本發明之一實施例的龍眼殼萃取物提升血球細胞中CCT5基因、CCT6A基因、CCT8基因、Pink1基因、Atg1基因、Atg8基因、及FOXO3基因表現量之效果的長條圖。* p值<0.05;** p<0.01;*** p<0.001。 Fig. 2 is a bar graph showing the effect of longan shell extract on enhancing the expression of CCT5 gene, CCT6A gene, CCT8 gene, Pink1 gene, Atg1 gene, Atg8 gene, and FOXO3 gene in hemocytes according to an embodiment of the present invention. *p-value<0.05;**p<0.01;***p<0.001.
圖3係為本發明之一實施例的蕎麥萃取物提升血球細胞中CCT2基因、及CCT5基因表現量之效果的長條圖。* p值<0.05。 Fig. 3 is a bar graph showing the effect of buckwheat extract on increasing the expression levels of CCT2 gene and CCT5 gene in hemocytes according to an embodiment of the present invention. *p-value <0.05.
圖4係為本發明之一實施例的天山雪蓮萃取物提升皮膚細胞中CCT6A基因、CCT7基因、Atg1基因、Atg8基因、SIRT1基因、及FOXO3基因表現量之效果的長條圖。* p值<0.05;** p<0.01。 Fig. 4 is a bar graph showing the effect of Saussurea tianshanensis extract on enhancing the expression of CCT6A gene, CCT7 gene, Atg1 gene, Atg8 gene, SIRT1 gene, and FOXO3 gene in skin cells according to one embodiment of the present invention. *p-value<0.05;**p<0.01.
圖5係為本發明之一實施例的龍眼殼萃取物提升皮膚細胞中CCT2基因、CCT5基因、CCT7基因、Pink1基因、Atg1基因、Atg8基因、SIRT1基因、及FOXO3基因表現量之效果的長條圖。* p值<0.05;** p<0.01;*** p<0.001。 Figure 5 is a strip showing the effect of the longan shell extract on enhancing the expression of CCT2 gene, CCT5 gene, CCT7 gene, Pink1 gene, Atg1 gene, Atg8 gene, SIRT1 gene, and FOXO3 gene in skin cells according to an embodiment of the present invention picture. *p-value<0.05;**p<0.01;***p<0.001.
圖6係為本發明之一實施例的蕎麥萃取物提升皮膚細胞中CCT2基因、CCT5基因、CCT6A基因、CCT7基因、CCT8基因、及Pink1基因表現量之效果的長條圖。*** p值<0.001。 Fig. 6 is a bar graph showing the effect of buckwheat extract on enhancing the expression levels of CCT2 gene, CCT5 gene, CCT6A gene, CCT7 gene, CCT8 gene, and Pink1 gene in skin cells according to an embodiment of the present invention. ***p-value <0.001.
圖7係為本發明之一實施例的天山雪蓮萃取物提升心血管細胞中CCT2基因、CCT6A基因、CCT7基因、CCT8基因、Pink1基因、Atg1基因、及SIRT1基因表現量之效果的長條圖。* p值<0.05;** p<0.01;*** p<0.001。 7 is a bar graph showing the effect of Saussurea tianshanensis extract on enhancing the expression of CCT2 gene, CCT6A gene, CCT7 gene, CCT8 gene, Pink1 gene, Atg1 gene, and SIRT1 gene in cardiovascular cells according to one embodiment of the present invention. *p-value<0.05;**p<0.01;***p<0.001.
圖8係為本發明之一實施例的龍眼殼萃取物提升心血管細胞中CCT2基因、CCT5基因、CCT6A基因、CCT7基因、CCT8基因、Atg1基因、SIRT1基因、及FOXO3基因表現量之效果的長條圖。* p值<0.05;** p<0.01;*** p<0.001。 Figure 8 is a longan shell extract of one embodiment of the present invention to enhance the expression of CCT2 gene, CCT5 gene, CCT6A gene, CCT7 gene, CCT8 gene, Atg1 gene, SIRT1 gene, and FOXO3 gene expression in cardiovascular cells. bar chart. *p-value<0.05;**p<0.01;***p<0.001.
圖9係為本發明之一實施例的蕎麥萃取物提升心血管細胞中CCT2基因、CCT5基因、CCT6A基因、CCT7基因、CCT8基因、Pink1基因、Atg1基因、SIRT1基因、及FOXO3基因表現量之效果的長條圖。* p值<0.05;** p<0.01;*** p<0.001。 Figure 9 shows the effect of buckwheat extract in one embodiment of the present invention on enhancing the expression of CCT2 gene, CCT5 gene, CCT6A gene, CCT7 gene, CCT8 gene, Pink1 gene, Atg1 gene, SIRT1 gene, and FOXO3 gene in cardiovascular cells bar chart. *p-value<0.05;**p<0.01;***p<0.001.
圖10係為本發明之一實施例的龍眼殼萃取物及蕎麥萃取物提升視網膜細胞中CCTs基因、Pink1基因、Atg8基因、SIRT1基因、或FOXO3基因表現量之效果的長條圖。** p<0.01;*** p<0.001。 Figure 10 is a bar graph showing the effect of longan shell extract and buckwheat extract on enhancing the expression of CCTs gene, Pink1 gene, Atg8 gene, SIRT1 gene, or FOXO3 gene in retinal cells according to an embodiment of the present invention. **p<0.01;***p<0.001.
圖11係為本發明之一實施例的植物萃取物的組合物提升CCTs基因表現量之效果的長條圖。* p<0.05;*** p<0.001。 Fig. 11 is a bar graph showing the effect of a composition of plant extracts according to an embodiment of the present invention on enhancing the gene expression of CCTs . *p<0.05;***p<0.001.
圖12係為本發明之一實施例的植物萃取物的組合物提升Atg1基因及Atg8基因表現量之效果的長條圖。* p<0.05;*** p<0.001。 Fig. 12 is a bar graph showing the effect of the composition of the plant extract according to one embodiment of the present invention on enhancing the expression of Atg1 gene and Atg8 gene. *p<0.05;***p<0.001.
圖13係為本發明之一實施例的植物萃取物的組合物提升NADSYN基因、MRPS5基因、及SOD3基因表現量之效果的長條圖。* p<0.05;*** p<0.001。 Fig. 13 is a bar graph showing the effects of the composition of plant extracts according to one embodiment of the present invention on enhancing the expression levels of NADSYN gene, MRPS5 gene, and SOD3 gene. *p<0.05;***p<0.001.
圖14係為本發明之一實施例的植物萃取物的組合物提升TERT基因表現量之效果的長條圖。*** p<0.001。 Fig. 14 is a bar graph showing the effect of the composition of plant extracts according to one embodiment of the present invention on enhancing the expression level of TERT gene. ***p<0.001.
圖15係為本發明之一實施例的植物萃取物的組合物提升GSH含量之效果的長條圖。** p<0.01;*** p<0.001。 Fig. 15 is a bar graph showing the effect of increasing the GSH content of the composition of plant extracts according to one embodiment of the present invention. **p<0.01; ***p<0.001.
本文中所使用數值為近似值,所有實驗數據皆表示在20%的範圍內,較佳為在10%的範圍內,最佳為在5%的範圍內。 The numerical values used herein are approximate values, and all experimental data are expressed within the range of 20%, preferably within the range of 10%, and most preferably within the range of 5%.
使用Excel軟體進行統計分析。數據以平均值±標準差(SD)表示,個此之間的差異以學生t檢驗(student's t-test)分析。 Statistical analysis was performed using Excel software. The data are expressed as mean ± standard deviation (SD), and the differences between them are analyzed by student's t -test.
天山雪蓮(Smallanthus sonchifolius)為菊科(Compositae)菊薯屬(Smallanthus)多年生草本植物,又稱菊薯,英文名為Peruvian ground apple,地下塊根肥大,可供食用且具有清涼解熱、降脂、及幫助排便的功效。 Tianshan Snow Lotus ( Smallanthus sonchifolius ) is a perennial herbaceous plant of the genus Smallanthus ( Smallanthus ) in the family Compositae , also known as Chrysanthemum potato, and its English name is Peruvian ground apple. Aids in defecation.
龍眼(Euphoria longana Lam.)為無患子科(Sapindaceae)龍眼屬(Euphoria)常綠喬木植物,英文名為Longan,龍眼根具有通經絡功效;葉具有清熱解毒之功效;果核具有止血、止痛之功效;果實味甜且具有補氣血、安神之功效;果皮(即為龍眼殼)具有清熱涼血的功效。 Longan ( Euphoria longana Lam. ) is an evergreen tree plant of Sapindaceae ( Sapindaceae ) longan genus ( Euphoria ). The English name is Longan. The fruit is sweet and has the effect of nourishing qi and blood and calming the nerves; the peel (that is, longan shell) has the effect of clearing away heat and cooling blood.
蕎麥(Fagopyrum esculentum Moench.)為蓼科(Polygonaceae)蕎麥屬(Fagopyrum)一年生草本植物,又稱三角麥,英文名為Common buckwheat,蕎麥莖及葉具有止血、降血壓之功效;種子則具有消腫、解毒、退燒之功效。 Buckwheat ( Fagopyrum esculentum Moench. ) is an annual herbaceous plant of the genus Fagopyrum in the Polygonaceae family. , detoxification, antipyretic effect.
如本文中所使用的,用語「天山雪蓮萃取物」意為天山雪蓮的癒傷組織與溶劑以1:1-5(w/w)比例經一特定時間與溫度萃取而得。 As used herein, the term "Tianshan Saussurea extract" means that the callus of Tianshan Saussurea and solvent are extracted at a ratio of 1:1-5 (w/w) for a specific time and temperature.
如本文中所使用的,用語「龍眼殼萃取物」意為龍眼殼與溶劑以1:5-10(w/w)比例經一特定時間與溫度萃取而得。 As used herein, the term "longan shell extract" means that longan shell and solvent are extracted at a ratio of 1:5-10 (w/w) for a specific time and temperature.
如本文中所使用的,用語「蕎麥萃取物」意為蕎麥的種皮與溶劑以1:10-15(w/w)比例經一特定時間與溫度萃取而得。 As used herein, the term "buckwheat extract" means that buckwheat seed coat and solvent are extracted at a ratio of 1:10-15 (w/w) for a specific time and temperature.
如本文中所使用的,用語「植物萃取物的組合物」意為將前述之天山雪蓮萃取物、前述之龍眼殼萃取物、及前述之蕎麥萃取物以2.4-3.6:129.6-194.4:128.8-193.2比例混合而得之組合物。 As used herein, the term "composition of plant extracts" means to combine the aforementioned Saussurea tianshanensis extract, the aforementioned longan shell extract, and the aforementioned buckwheat extract at a ratio of 2.4-3.6:129.6-194.4:128.8- The composition obtained by mixing in a ratio of 193.2.
本發明提供一種植物萃取物用於製備抗老化之組合物的用途,本發明之植物萃取物係為一天山雪蓮萃取物、一龍眼殼萃取物、一蕎麥萃取物、及其任意組合所獲得,其可用於提升與抗老化相關之基因的表現量,能夠全面的提升抗老化活性,且能同時提升GSH的含量,能全面的提升人的的抗氧化活性,以使體內反轉回青春有活力的狀態。 The present invention provides the use of a plant extract for preparing an anti-aging composition. The plant extract of the present invention is obtained from a snow lotus extract, a longan shell extract, a buckwheat extract, and any combination thereof. It can be used to increase the expression of genes related to anti-aging, can comprehensively enhance anti-aging activity, and can increase the content of GSH at the same time, and can comprehensively enhance the antioxidant activity of people, so that the body can return to youthful vitality status.
同時,本發明用於製備抗老化之組合物,亦可包含一有效量之植物萃取物及一醫藥上可接受之載體,該組合物係一醫藥品、一食品或一保養品。 At the same time, the anti-aging composition of the present invention may also include an effective amount of plant extract and a pharmaceutically acceptable carrier, and the composition is a medicine, a food or a skin care product.
以下將詳細說明本發明天山雪蓮萃取物、龍眼殼萃取物、及蕎麥萃取物之詳細萃取方法;本發明天山雪蓮萃取物、龍眼殼萃取物、及蕎麥萃取物分別提升全身性、皮膚細胞、心血管細胞、及/或視網膜細胞中抗老化基因表現量之功效測試;以及本發明植物萃取物的組合物提升抗老化基因表現量、及提升GSH含量之功效測試。以證實本發明之植物萃取物能有效且全面的提升抗老化其抗氧化,以使體內反轉回青春有活力的狀態。 The detailed extraction methods of the Tianshan Snow Lotus Extract, Longan Shell Extract, and Buckwheat Extract of the present invention will be described in detail below; Efficacy test of anti-aging gene expression in vascular cells and/or retinal cells; and efficacy test of enhancing anti-aging gene expression and increasing GSH content with the composition of the plant extract of the present invention. To prove that the plant extracts of the present invention can effectively and comprehensively improve anti-aging and anti-oxidation, so that the body can return to a youthful and energetic state.
在本發明之一實施例中,首先將天山雪蓮的癒傷組織與水、醇、或醇水混合物之萃取溶劑,萃取溶劑較佳為水,以1:1-5之重量比混合,均質後在溶劑中以50-100℃進行萃取0.5-2小時後,將粗萃取物冷卻至室溫,並將該粗萃取物以400mesh之濾網過濾以獲得濾液,其中萃取溫度較佳為70-100℃。最後,將該濾液於45-70℃進行減壓濃縮後,即得到本發明之天山雪蓮萃取物。 In one embodiment of the present invention, first, the callus of Snow Lotus Tianshan is mixed with water, alcohol, or an extraction solvent of a mixture of alcohol and water, the extraction solvent is preferably water, and mixed with a weight ratio of 1:1-5, after homogenization After extracting in a solvent at 50-100°C for 0.5-2 hours, cool the crude extract to room temperature, and filter the crude extract with a 400mesh filter to obtain a filtrate, wherein the extraction temperature is preferably 70-100 ℃. Finally, after the filtrate is concentrated under reduced pressure at 45-70° C., the Snow Lotus extract of the present invention is obtained.
在本發明之一實施例中,首先將龍眼殼組織與水、醇、或醇水混合物之萃取溶劑,萃取溶劑較佳為水,以1:5-10之重量比混合,均質後在溶劑中以50-100℃進行萃取0.5-2小時後,將粗萃取物冷卻至室溫,並將該粗萃取物以400mesh之濾網過濾以獲得濾液,其中萃取溫度較佳為70-100℃。最後,將該濾液於45-70℃進行減壓濃縮後,即得到本發明之龍眼殼萃取物。 In one embodiment of the present invention, the longan shell tissue is first mixed with water, alcohol, or an extraction solvent of a mixture of alcohol and water. The extraction solvent is preferably water, mixed at a weight ratio of 1:5-10, and mixed in the solvent after homogenization After extraction at 50-100°C for 0.5-2 hours, the crude extract is cooled to room temperature and filtered through a 400 mesh filter to obtain a filtrate, wherein the extraction temperature is preferably 70-100°C. Finally, the filtrate is concentrated under reduced pressure at 45-70°C to obtain the longan shell extract of the present invention.
在本發明之一實施例中,首先將蕎麥的種皮與水、醇、或醇水混合物之萃取溶劑,萃取溶劑較佳為水,以1:10-15之重量比混合,均質後在溶劑中以50-100℃進行萃取0.5-2小時後,將粗萃取物冷卻至室溫,並將該粗萃取物以400mesh之濾網過濾以獲得濾液,其中萃取溫度較佳為70-100℃。最後,將該濾液於45-70℃進行減壓濃縮後,即得到本發明之蕎麥萃取物。 In one embodiment of the present invention, first, the seed coat of buckwheat is mixed with water, alcohol, or an extraction solvent of a mixture of alcohol and water. The extraction solvent is preferably water, mixed in a weight ratio of 1:10-15, and mixed in the solvent after homogenization After extraction at 50-100°C for 0.5-2 hours, the crude extract is cooled to room temperature and filtered through a 400 mesh filter to obtain a filtrate, wherein the extraction temperature is preferably 70-100°C. Finally, after the filtrate is concentrated under reduced pressure at 45-70° C., the buckwheat extract of the present invention is obtained.
本發明之一實施例以人類周邊血液單核球細胞(Human peripheral blood mononuclear cell,PBMC)測試本發明之天山雪蓮萃取物、龍眼殼 萃取物、及蕎麥萃取物提升全身性抗老化基因表現量之功效測試。其中,該人類周邊血液單核球細胞係購自美國典型培養物保藏中心,編號為ATCC® PCS-800-011TM,且培養於X-VIVOTM 10 Serum-free hematopoietic cell medium(購自Lonza,瑞士,編號BE02-055Q)中。 One embodiment of the present invention uses human peripheral blood mononuclear cells (Human peripheral blood mononuclear cells, PBMC) to test whether the Tianshan Snow Lotus Extract, Longan Shell Extract, and Buckwheat Extract of the present invention can enhance the expression of systemic anti-aging genes efficacy test. Wherein, the human peripheral blood mononuclear cell line was purchased from the American Type Culture Collection, numbered ATCC® PCS- 800-011™ , and cultured in X-VIVO ™ 10 Serum-free hematopoietic cell medium (purchased from Lonza, Switzerland, No. BE02-055Q).
首先,將1×105個PBMC細胞培養於含有2mL上述細胞培養液之6孔培養盤中,於37℃培養16-18小時,接著將細胞分成以下四組:(1)僅加入細胞培養液之控制組、(2)加入0.5%(v/v)本發明之天山雪蓮萃取物之實驗組、(3)加入0.25%(v/v)本發明之龍眼殼萃取物之實驗組、及(4)加入0.125%(v/v)本發明之蕎麥萃取物之實驗組,並將該些組別之細胞分別於37℃下作用24小時或48小時後,測試各組PBMC細胞中目標基因的表現量;其中,該天山雪蓮萃取物、該龍眼殼萃取物、及該蕎麥萃取物係以水為萃取溶劑。首先,將PBMC細胞以細胞裂解液(RB buffer,購自Geanaid公司,臺灣,Cat No.RBD300)回收細胞後,使用RNA萃取試劑套組(購自Geneaid公司,臺灣,Cat No.RBD300)分別收集該四組細胞內之RNA,接著利用SuperScript® III反轉錄酶(購自Invitrogene公司,美國,編號18080-051)以2000ng之萃取RNA為模板,並以表1之組合引子及反轉錄酶進行反轉錄作用,以產生該些基因之mRNA所相應之cDNA產物,接著利用ABI StepOnePlusTM Real-Time PCR system(Thermo Fisher Scientific公司,美國),以及KAPA SYBR FAST(購自Sigma公司,美國,編號38220000000)將該四組反轉錄後產物分別以表1之組合引子進行定量即時聚合酶連鎖反應(Quantitative real-time polymerase chain reaction,qPCR)試驗,條件為95℃反應1秒,60℃反應20秒,總共40個迴圈。用以定量CCT2基因、CCT5基因、CCT6A基因、CCT7基因、CCT8基因、Pink1基因、Parkin基因、Atg1基因、Atg8基因、SIRT1基因、FOXO3基因、NADSYN基因、MRPS5基因、及UBL-5基因之mRNA的表現量,其中定量數值係取由閾值循環數(Ct),而目標基因的mRNA相對量係推導自方程式2-△△Ct,其中△CT=CT比較組或實驗組目標基因/控制組目標基因-CT GAPDH(甘油醛-3-
磷酸脫氫酶,Glyceraldehyde-3-phosphate dehydrogenase);△△CT=CT比較組或實驗組目標基因-CT控制組目標基因;各組中各基因的fold change則為2-△△Ct。接著,再利用Excel軟體決定變異係數與是否在統計上具有顯著差異(*p值<0.05;**p值<0.01;***p值<0.001)。
First, 1×10 5 PBMC cells were cultured in a 6-well culture dish containing 2 mL of the above-mentioned cell culture medium, and cultured at 37°C for 16-18 hours, and then the cells were divided into the following four groups: (1) Add only the cell culture medium The control group, (2) the experimental group adding 0.5% (v/v) of the Saussurea chinensis extract of the present invention, (3) the experimental group adding 0.25% (v/v) of the longan shell extract of the present invention, and ( 4) Add 0.125% (v/v) of the buckwheat extract of the present invention to the experimental group, and act on the cells of these groups for 24 hours or 48 hours at 37°C respectively, and test the expression of the target gene in the PBMC cells of each group. Performance; Wherein, the Tianshan Snow Lotus extract, the longan shell extract, and the buckwheat extract use water as the extraction solvent. First, the PBMC cells were recovered with cell lysate (RB buffer, purchased from Geanaid Company, Taiwan, Cat No. RBD300), and then collected separately using the RNA extraction kit (purchased from Geneaid Company, Taiwan, Cat No. RBD300) The RNA in the four groups of cells was then reverse-transcriptase (purchased from Invitrogene, the U.S., No. 18080-051 ) using 2000 ng of extracted RNA as a template, and reversed with the combined primers and reverse transcriptase in Table 1. Transcription, to produce the cDNA products corresponding to the mRNA of these genes, then use ABI StepOnePlus TM Real-Time PCR system (Thermo Fisher Scientific Company, the United States), and KAPA SYBR FAST (purchased from Sigma Company, the United States, No. 38220000000) The four sets of reverse-transcribed products were subjected to quantitative real-time polymerase chain reaction (qPCR) test with the combined primers in Table 1. The conditions were 95°C for 1 second and 60°C for 20 seconds. 40 loops. For quantifying the mRNA of CCT2 gene, CCT5 gene, CCT6A gene, CCT7 gene, CCT8 gene, Pink1 gene, Parkin gene, Atg1 gene, Atg8 gene, SIRT1 gene, FOXO3 gene, NADSYN gene, MRPS5 gene, and UBL-5 gene Expression, where the quantitative value is taken from the threshold cycle number (Ct), and the relative amount of mRNA of the target gene is derived from
CCT基因為折疊蛋白(Chaperonin)的一種,主要功能為矯正錯誤摺疊的蛋白質,並將無法成功修復之蛋白質送進蛋白質水解酶複合體(Proteasome)中進行水解,先前研究已指若此蛋白質調控之重複使用系統發生故障,會導致錯誤摺疊的蛋白質會聚集在細胞中,並造成細胞功能衰退及加速細胞的老化與死亡,因此被認為與個體之老化調節相關。 The CCT gene is a type of chaperonin, whose main function is to correct misfolded proteins and send the proteins that cannot be successfully repaired to the proteasome for hydrolysis. Previous studies have pointed out that if this protein regulates The failure of the reuse system will lead to the accumulation of misfolded proteins in cells, which will cause the decline of cell function and accelerate the aging and death of cells, so it is considered to be related to the regulation of aging in individuals.
Pink1基因為一種位在粒線體的絲胺酸/蘇胺酸蛋白激酶(Serine/threonine protein kinase),其功能為保護線粒體在細胞壓力期間發生故障,已知該基因之突變與帕金森氏症有關,而先前研究更指出該基因的過量表現能夠增加小鼠的壽命,因此也被認為與個體之老化調節有關。 The Pink1 gene is a serine/threonine protein kinase located in mitochondria. Its function is to protect mitochondria from failure during cellular stress. Mutations in this gene are known to be associated with Parkinson's disease Related, and previous studies have pointed out that the excessive expression of this gene can increase the lifespan of mice, so it is also considered to be related to the regulation of aging in individuals.
Parkin基因為一種存在於泛素-蛋白酶體系(Ubiquitin-proteasome system)中之酵素,並作為蛋白質分解的調節劑,已知該基因之突變與帕金森氏症有關,且先前研究亦指出增加該基因的表現量能夠延緩細胞的老化作用,因此被認為與細胞的老化作用相關。 The Parkin gene is an enzyme that exists in the ubiquitin-proteasome system (Ubiquitin-proteasome system) and acts as a regulator of protein breakdown. It is known that the mutation of this gene is related to Parkinson's disease, and previous studies have also pointed out that the increase of this gene The expression level of can delay the aging effect of cells, so it is considered to be related to the aging effect of cells.
Atg基因則為自噬作用相關基因,會參與細胞中廢物降解、及循環的自噬作用,先前研究指出該基因的過量表現,能夠延長小鼠的壽命,因此被認為與細胞的老化作用相關。 The Atg gene is an autophagy-related gene, which is involved in the degradation of waste in cells and autophagy in the cycle. Previous studies have pointed out that the overexpression of this gene can prolong the lifespan of mice, so it is considered to be related to the aging of cells.
先前研究已指出和年老的小鼠相比,年輕的小鼠體內含有較多的NAD+;且增加年老小鼠體內的NAD+濃度,能使其生理狀況更為年輕,因此NAD+被認為與延緩個體老化相關,研究結果已知SIRT1基因、FOXO3基因、NADSYN基因、MRPS5基因、UBL-5基因、及SOD3基因與調節NAD+相關。 Previous studies have pointed out that compared with old mice, young mice contain more NAD + in their bodies; and increasing the concentration of NAD + in old mice can make their physiological conditions younger, so NAD + is It is considered to be related to delaying the aging of individuals, and the research results have shown that SIRT1 gene, FOXO3 gene, NADSYN gene, MRPS5 gene, UBL-5 gene, and SOD3 gene are related to the regulation of NAD + .
本發明之天山雪蓮萃取物提升血球細胞中抗老化基因之表現量的實驗結果如圖1所示。經本發明之天山雪蓮萃取物作用48小時後,相較於控制組,能提升PBMC細胞中CCT2基因、CCT5基因、及CCT6A基因之表現量達約1.2-1.4倍不等,其它基因表現量則與控制組差異不大(結果未顯示),其中CCT6A基因之表現量具顯著差異。此結果顯示本發明之天山雪蓮萃取物能有效提升PBMC細胞中CCT2基因、CCT5基因、及CCT6A基因之表現量,能有效提升全身性抗老化的能力。 The experimental results of the Snow Lotus extract of the present invention to enhance the expression of anti-aging genes in blood cells are shown in FIG. 1 . After being treated with the Saussurea tianshanensis extract of the present invention for 48 hours, compared with the control group, the expression levels of CCT2 gene, CCT5 gene, and CCT6A gene in PBMC cells can be increased by about 1.2-1.4 times, and the expression levels of other genes are similar to those of the control group. There was little difference in the control group (results not shown), but there was a significant difference in the expression of CCT6A gene. The results show that the Saussurea tianshanensis extract of the present invention can effectively increase the expression levels of CCT2 gene, CCT5 gene, and CCT6A gene in PBMC cells, and can effectively improve the systemic anti-aging ability.
本發明之龍眼殼萃取物提升血球細胞中抗老化基因之表現量的實驗結果如圖2所示。經本發明之龍眼殼萃取物作用24小時後,相較於控制組,能顯著提升PBMC細胞中CCT5基因、CCT6A基因、CCT8基因、Pink1基因、Atg1基因、Atg8基因、及FOXO3基因之表現量達約1.3-20倍不等,其它基因表現量則與控制組差異不大(結果未顯示)。此結果顯示本發明之龍眼殼萃取物能有效提升PBMC細胞中CCT5基因、CCT6A基因、CCT8基因、Pink1基因、Atg1基因、Atg8基因、及FOXO3基因之表現量,能有效提升全身性抗老化的能力。 The experimental results of the longan shell extract of the present invention increasing the expression of anti-aging genes in blood cells are shown in FIG. 2 . After being treated with the longan shell extract of the present invention for 24 hours, compared with the control group, the expression levels of CCT5 gene, CCT6A gene, CCT8 gene, Pink1 gene, Atg1 gene, Atg8 gene, and FOXO3 gene in PBMC cells can be significantly increased by about 1.3-20 times, and the expression of other genes had little difference with the control group (results not shown). This result shows that the longan shell extract of the present invention can effectively increase the expression of CCT5 gene, CCT6A gene, CCT8 gene, Pink1 gene, Atg1 gene, Atg8 gene, and FOXO3 gene in PBMC cells, and can effectively improve the ability of systemic anti-aging .
本發明之蕎麥萃取物提升血球細胞中抗老化基因之表現量的實驗結果如圖3所示。經本發明之蕎麥萃取物作用48小時後,相較於控制組,能提升PBMC細胞中CCT2基因、及CCT5基因之表現量達約1.2倍,其它基因表現 量則與控制組差異不大(結果未顯示),其中CCT2基因之表現量具顯著差異。此結果顯示本發明之蕎麥萃取物能有效提升PBMC細胞中CCT2基因、及CCT5基因之表現量,能有效提升全身性抗老化的能力。 The experimental results of the buckwheat extract of the present invention increasing the expression of anti-aging genes in blood cells are shown in FIG. 3 . After being treated with the buckwheat extract of the present invention for 48 hours, compared with the control group, the expression levels of CCT2 gene and CCT5 gene in PBMC cells can be increased by about 1.2 times, and the expression levels of other genes are not significantly different from the control group (results not shown shown), in which the expression of CCT2 gene was significantly different. The results show that the buckwheat extract of the present invention can effectively increase the expression levels of CCT2 gene and CCT5 gene in PBMC cells, and can effectively improve the systemic anti-aging ability.
本發明之一實施例以人類皮膚纖維母細胞(Human skin fibroblast)CCD-966SK細胞測試本發明之天山雪蓮萃取物、龍眼殼萃取物、及蕎麥萃取物提升皮膚細胞中抗老化基因表現量之功效測試。其中,該CCD-966SK細胞係購自美國典型培養物保藏中心(ATCC,美國),編號為ATCC® CRL-1881,且該細胞係培養於含有10%之胎牛血清(Fetal Bovine Serum)以及90%之Minimum Essential Medium(MEM)的培養液(購自Gibco,美國),其中含有1mM之丙酮酸鈉(Sodium pyruvate,購自Gibco,美國)、及1%之青黴素-鏈黴素(penicillin/streptomycin)。 One embodiment of the present invention uses human skin fibroblast (Human skin fibroblast) CCD-966SK cells to test the efficacy of the Tianshan snow lotus extract, longan shell extract, and buckwheat extract of the present invention to enhance the expression of anti-aging genes in skin cells test. Wherein, the CCD-966SK cell line was purchased from the American Type Culture Collection (ATCC, U.S.), the number is ATCC ® CRL-1881, and the cell line was cultured in 10% fetal bovine serum (Fetal Bovine Serum) and 90 The culture solution of Minimum Essential Medium (MEM) (purchased from Gibco, U.S.) containing 1 mM sodium pyruvate (Sodium pyruvate, purchased from Gibco, U.S.), and 1% penicillin-streptomycin (penicillin/streptomycin ).
首先,將1.5x105個CCD-966SK細胞培養於每孔含有2mL上述培養液之6孔培養盤中,於37℃培養16-18小時,接著將細胞分成以下四組:(1)僅加入細胞培養液之控制組、(2)加入0.5%(v/v)本發明之天山雪蓮萃取物之實驗組、(3)加入0.5%(v/v)本發明之龍眼殼萃取物之實驗組、及(4)加入0.125%(v/v)本發明之蕎麥萃取物之實驗組,並將該些組別之細胞於37℃下作用24小時或48小時後,測試各組CCD-966SK細胞中目標基因的表現量;其中,該天山雪蓮萃取物、該龍眼殼萃取物、及該蕎麥萃取物係以水為萃取溶劑。接著,將該四組之CCD-966SK細胞以細胞裂解液回收細胞後,以實施例4中所述之步驟定量該四組CCD-966SK細胞中CCT2基因、CCT5基因、CCT6A基因、CCT7基因、CCT8基因、Pink1基因、Parkin基因、Atg1基因、Atg8基因、SIRT1基因、FOXO3基因、NADSYN基因、MRPS5基因、及UBL-5基因之mRNA表現量,再利用Excel 軟體決定變異係數與是否在統計上具有顯著差異(*p值<0.05;**p值<0.01;***p值<0.001)。 First, 1.5x105 CCD-966SK cells were cultured in a 6-well culture dish containing 2 mL of the above-mentioned culture solution in each well, and cultured at 37°C for 16-18 hours, and then the cells were divided into the following four groups: (1) Add only cells The control group of the culture medium, (2) the experimental group adding 0.5% (v/v) of the Tianshan Snow Lotus extract of the present invention, (3) the experimental group of adding 0.5% (v/v) of the longan shell extract of the present invention, And (4) add 0.125% (v/v) of the buckwheat extract of the present invention to the experimental group, and after the cells of these groups acted at 37°C for 24 hours or 48 hours, test the CCD-966SK cells in each group The expression level of the target gene; wherein, the extract of Snow Lotus Tianshan, the extract of longan husk, and the extract of buckwheat use water as the extraction solvent. Then, after the four groups of CCD-966SK cells were recovered with cell lysate, the CCT2 gene, CCT5 gene, CCT6A gene, CCT7 gene, CCT7 gene, CCT8 gene, Pink1 gene, Parkin gene, Atg1 gene, Atg8 gene, SIRT1 gene, FOXO3 gene, NADSYN gene, MRPS5 gene, and UBL-5 gene mRNA expression, and then use Excel software to determine the coefficient of variation and whether it is statistically Significantly different (*p-value<0.05;**p-value<0.01;***p-value<0.001).
本發明之天山雪蓮萃取物提升皮膚細胞中抗老化基因之表現量的實驗結果如圖4所示。經本發明之天山雪蓮萃取物作用24小時後,相較於控制組,能顯著提升CCD-966SK細胞中CCT6A基因、CCT7基因、Atg1基因、及Atg8基因之表現量達約1.1-2.2倍不等,SIRT1基因、及FOXO3基因之表現量則約為1.05倍,其它基因表現量則與控制組差異不大(結果未顯示)。此結果顯示本發明之天山雪蓮萃取物能有效提升CCD-966SK細胞中CCT6A基因、CCT7基因、Atg1基因、Atg8基因、SIRT1基因、及FOXO3基因之表現量,能有效提升皮膚細胞抗老化的能力。 The experimental results of the Snow Lotus extract of the present invention to enhance the expression of anti-aging genes in skin cells are shown in FIG. 4 . After being treated with the Saussurea tianshanensis extract of the present invention for 24 hours, compared with the control group, the expression levels of CCT6A gene, CCT7 gene, Atg1 gene, and Atg8 gene in CCD-966SK cells can be significantly increased by about 1.1-2.2 times. The expression levels of SIRT1 gene and FOXO3 gene were about 1.05 times, and the expression levels of other genes were not significantly different from those of the control group (results not shown). The results show that the Saussurea tianshanensis extract of the present invention can effectively increase the expression levels of CCT6A gene, CCT7 gene, Atg1 gene, Atg8 gene, SIRT1 gene, and FOXO3 gene in CCD-966SK cells, and can effectively improve the anti-aging ability of skin cells.
本發明之龍眼殼萃取物提升皮膚細胞中抗老化基因之表現量的實驗結果如圖5所示。經本發明之龍眼殼萃取物作用24小時後,相較於控制組,能提升CCD-966SK細胞中CCT2基因、CCT5基因、CCT7基因、Pink1基因、Atg1基因、Atg8基因、SIRT1基因、及FOXO3基因之表現量達約1.1-1.9倍不等,其它基因表現量則與控制組差異不大(結果未顯示),其中Pink1基因、SIRT1基因、及FOXO3基因之表現量具顯著差異。此結果顯示本發明之龍眼殼萃取物能有效提升CCD-966SK細胞中CCT2基因、CCT5基因、CCT7基因、Pink1基因、Atg1基因、Atg8基因、SIRT1基因、及FOXO3基因之表現量,能有效提升皮膚細胞抗老化的能力。 The experimental results of the longan shell extract of the present invention increasing the expression of anti-aging genes in skin cells are shown in FIG. 5 . After being treated with the longan shell extract of the present invention for 24 hours, compared with the control group, the levels of CCT2 gene, CCT5 gene, CCT7 gene, Pink1 gene, Atg1 gene, Atg8 gene, SIRT1 gene, and FOXO3 gene in CCD-966SK cells can be increased. The expression levels ranged from 1.1 to 1.9 times, and the expression levels of other genes were not significantly different from those in the control group (results not shown). Among them, the expression levels of the Pink1 gene, SIRT1 gene, and FOXO3 gene were significantly different. This result shows that the longan shell extract of the present invention can effectively increase the expression levels of CCT2 gene, CCT5 gene, CCT7 gene, Pink1 gene, Atg1 gene, Atg8 gene, SIRT1 gene, and FOXO3 gene in CCD-966SK cells, and can effectively improve skin The ability of cells to resist aging.
本發明之蕎麥萃取物提升皮膚細胞中抗老化基因之表現量的實驗結果如圖6所示。經本發明之蕎麥萃取物作用48小時後,相較於控制組,能顯著提升CCD-966SK細胞中CCT2基因、CCT6A基因、CCT7基因、及CCT8基因之表現量達約1.2-2.9倍不等,CCT5基因、及Pink1基因之表現量則約為1.2倍,其它基因表現量則與控制組差異不大(結果未顯示)。此結果顯示本發明之蕎麥 萃取物能有效提升CCD-966SK細胞中CCT2基因、CCT5基因、CCT6A基因、CCT7基因、CCT8基因、及Pink1基因之表現量,能有效提升皮膚細胞抗老化的能力。 The experimental results of the buckwheat extract of the present invention increasing the expression of anti-aging genes in skin cells are shown in FIG. 6 . After being treated with the buckwheat extract of the present invention for 48 hours, compared with the control group, the expression levels of CCT2 gene, CCT6A gene, CCT7 gene, and CCT8 gene in CCD-966SK cells can be significantly increased by about 1.2-2.9 times, CCT5 The expression levels of genes and Pink1 gene were about 1.2 times, and the expression levels of other genes were not significantly different from those of the control group (results not shown). The results show that the buckwheat extract of the present invention can effectively increase the expression levels of CCT2 gene, CCT5 gene, CCT6A gene, CCT7 gene, CCT8 gene, and Pink1 gene in CCD-966SK cells, and can effectively improve the anti-aging ability of skin cells.
本發明之一實施例以人類臍帶靜脈/血管內皮細胞(Human umbilical vein/vascular endothelium cell,HUVEC)測試本發明之天山雪蓮萃取物、龍眼殼萃取物、及蕎麥萃取物提升心血管細胞中抗老化基因表現量之功效測試。其中,該HUVEC細胞係購自台灣生物資源保存與研究中心,編號為BCRC No.H-UV001ATCC® CRL-1730TM,且該細胞係培養於含有10mL之50x LSGS(購自Gibco,美國)之培養液Medium 200(購自Thermo,美國,編號M200500)中,其中含有及1%之青黴素-鏈黴素(penicillin/streptomycin)。 One embodiment of the present invention uses human umbilical vein/vascular endothelial cells (Human umbilical vein/vascular endothelium cell, HUVEC) to test that the Tianshan snow lotus extract, longan shell extract, and buckwheat extract of the present invention can enhance the anti-aging in cardiovascular cells Efficacy test of gene expression. Wherein, the HUVEC cell line was purchased from Taiwan Biological Resource Conservation and Research Center, the number is BCRC No.H-UV001ATCC ® CRL- 1730TM , and the cell line was cultured in a culture medium containing 10 mL of 50x LSGS (purchased from Gibco, the United States). Liquid Medium 200 (purchased from Thermo, the United States, No. M200500), which contains 1% penicillin-streptomycin (penicillin/streptomycin).
首先,將1.5x105個HUVEC細胞培養於每孔含有2mL上述培養液之6孔培養盤中,於37℃培養16-18小時,接著將細胞分成以下四組:(1)僅加入細胞培養液之控制組、(2)加入0.5%(v/v)本發明之天山雪蓮萃取物之實驗組、(3)加入0.5%(v/v)本發明之龍眼殼萃取物之實驗組、及(4)加入0.125%(v/v)本發明之蕎麥萃取物之實驗組,並將該些組別之細胞分別於37℃下作用48小時後,測試各組HUVEC細胞中目標基因的表現量;其中,該天山雪蓮萃取物、該龍眼殼萃取物、及該蕎麥萃取物係以水為萃取溶劑。接著,將該四組之HUVEC細胞以細胞裂解液回收細胞後,以實施例4中所述之步驟定量該四組HUVEC細胞中CCT2基因、CCT5基因、CCT6A基因、CCT7基因、CCT8基因、Pink1基因、Parkin基因、Atg1基因、Atg8基因、SIRT1基因、FOXO3基因、NADSYN基因、MRPS5基因、及UBL-5基因之mRNA表現量,再利用Excel軟體決定變異係數與是否在統計上具有顯著差異(*p值<0.05;**p值<0.01;***p值<0.001)。 First, 1.5x105 HUVEC cells were cultured in a 6-well culture dish containing 2 mL of the above-mentioned culture medium per well, and cultured at 37°C for 16-18 hours, and then the cells were divided into the following four groups: (1) Add only cell culture medium The control group, (2) the experimental group adding 0.5% (v/v) of the Saussurea tianshanensis extract of the present invention, (3) the experimental group adding 0.5% (v/v) of the longan shell extract of the present invention, and ( 4) Add 0.125% (v/v) of the buckwheat extract of the present invention to the experimental group, and react the cells of these groups at 37°C for 48 hours, then test the expression of the target gene in each group of HUVEC cells; Wherein, the Snow Lotus extract, the longan shell extract, and the buckwheat extract use water as the extraction solvent. Next, after the cells of the four groups of HUVEC cells were recovered with cell lysate, the CCT2 gene, CCT5 gene, CCT6A gene, CCT7 gene, CCT8 gene, and Pink1 gene in the four groups of HUVEC cells were quantified by the steps described in Example 4. , Parkin gene, Atg1 gene, Atg8 gene, SIRT1 gene, FOXO3 gene, NADSYN gene, MRPS5 gene, and UBL-5 gene mRNA expression, and then use Excel software to determine the coefficient of variation and whether there is a statistically significant difference (*p Value<0.05;**p-value<0.01;***p-value<0.001).
本發明之天山雪蓮萃取物提升心血管細胞中抗老化基因之表現量的實驗結果如圖7所示。經本發明之天山雪蓮萃取物作用後,相較於控制組,能顯著提升HUVEC細胞中CCT2基因、CCT6A基因、CCT7基因、CCT8基因、Pink1基因、Atg1基因、及SIRT1基因之表現量達約1.6-4.4倍不等,其它基因表現量則與控制組差異不大(結果未顯示)。此結果顯示本發明之天山雪蓮萃取物能有效提升HUVEC細胞中CCT2基因、CCT6A基因、CCT7基因、CCT8基因、Pink1基因、Atg1基因、及SIRT1基因之表現量,能有效提升心血管細胞抗老化的能力。 The experimental results of the Saussurea tianshanensis extract of the present invention to enhance the expression of anti-aging genes in cardiovascular cells are shown in FIG. 7 . After being treated with the Saussurea tianshanensis extract of the present invention, compared with the control group, the expression levels of CCT2 gene, CCT6A gene, CCT7 gene, CCT8 gene, Pink1 gene, Atg1 gene, and SIRT1 gene in HUVEC cells can be significantly increased by about 1.6- 4.4 times, and the expression of other genes had little difference with the control group (results not shown). This result shows that the Saussurea tianshanensis extract of the present invention can effectively increase the expression of CCT2 gene, CCT6A gene, CCT7 gene, CCT8 gene, Pink1 gene, Atg1 gene, and SIRT1 gene in HUVEC cells, and can effectively improve the anti-aging ability of cardiovascular cells. ability.
本發明之龍眼殼萃取物提升心血管細胞中抗老化基因之表現量的實驗結果如圖8所示。經本發明之龍眼殼萃取物作用後,相較於控制組,能顯著提升HUVEC細胞中CCT5基因、CCT6A基因、CCT7基因、CCT8基因、Atg1基因、SIRT1基因、及FOXO3基因之表現量達約1.8-4.3倍不等,CCT2基因之表現量則約為1.8倍、其它基因表現量則與控制組差異不大(結果未顯示)。此結果顯示本發明之龍眼殼萃取物能有效提升HUVEC細胞中CCT2基因、CCT5基因、CCT6A基因、CCT7基因、CCT8基因、Atg1基因、SIRT1基因、及FOXO3基因之表現量,能有效提升心血管細胞抗老化的能力。 The experimental results of the longan shell extract of the present invention increasing the expression of anti-aging genes in cardiovascular cells are shown in FIG. 8 . After being treated with the longan shell extract of the present invention, compared with the control group, the expression levels of CCT5 gene, CCT6A gene, CCT7 gene, CCT8 gene, Atg1 gene, SIRT1 gene, and FOXO3 gene in HUVEC cells can be significantly increased by about 1.8- 4.3 times, the expression of CCT2 gene was about 1.8 times, and the expression of other genes was not significantly different from the control group (results not shown). This result shows that the longan shell extract of the present invention can effectively increase the expression of CCT2 gene, CCT5 gene, CCT6A gene, CCT7 gene, CCT8 gene, Atg1 gene, SIRT1 gene, and FOXO3 gene in HUVEC cells, and can effectively enhance the expression of cardiovascular cell Anti-aging ability.
本發明之蕎麥萃取物提升心血管細胞中抗老化基因之表現量的實驗結果如圖9所示。經本發明之蕎麥萃取物作用後,相較於控制組,能顯著提升HUVEC細胞中CCT5基因、CCT6A基因、CCT7基因、CCT8基因、Pink1基因、Atg1基因、SIRT1基因、及FOXO3基因之表現量達約2-4倍不等,CCT2基因之表現量則約為1.1倍,其它基因表現量則與控制組差異不大(結果未顯示)。此結果顯示本發明之蕎麥萃取物能有效提升HUVEC細胞中CCT2基因、CCT5基因、CCT6A基因、CCT7基因、CCT8基因、Pink1基因、Atg1基因、SIRT1基因、及FOXO3基因之表現量,能有效提升心血管細胞抗老化的能力。 The experimental results of the buckwheat extract of the present invention increasing the expression of anti-aging genes in cardiovascular cells are shown in FIG. 9 . After being treated with the buckwheat extract of the present invention, compared with the control group, the expression levels of CCT5 gene, CCT6A gene, CCT7 gene, CCT8 gene, Pink1 gene, Atg1 gene, SIRT1 gene, and FOXO3 gene in HUVEC cells can be significantly improved by about 2-4 times, the expression of CCT2 gene was about 1.1 times, and the expression of other genes was not significantly different from the control group (results not shown). The results show that the buckwheat extract of the present invention can effectively increase the expression levels of CCT2 gene, CCT5 gene, CCT6A gene, CCT7 gene, CCT8 gene, Pink1 gene, Atg1 gene, SIRT1 gene, and FOXO3 gene in HUVEC cells, and can effectively enhance the heart rate. Ability of vascular cells to resist aging.
本發明之一實施例以人類視網膜色素上皮細胞(Human retinal pigment epithelial)ARPE-19細胞測試本發明之天山雪蓮萃取物、龍眼殼萃取物、及蕎麥萃取物提升皮膚細胞中抗老化基因表現量之功效測試。其中,該ARPE-19細胞係購自ATCC公司(美國),編號為CRL-2302,且該細胞係培養於含有10%之胎牛血清以及90%之DMEM/F12培養液,其中該培養液含有1:1比例之DMEM培養液(Dulbecco's Modified Eagle Medium,購自Gibco,美國,12100-046)與漢氏F12培養液(Ham's F12 Nutrient Mixture,購自Gibco,美國,12500-026),且含有0.5mM之丙酮酸鈉(sodium pyruvate)及15mM之4-羥乙基哌嗪乙磺酸(hydroxyethyl piperazineethanesulfonic acid,HEPES)緩衝溶液。 One embodiment of the present invention uses human retinal pigment epithelial (Human retinal pigment epithelial) ARPE-19 cells to test whether the extracts of Saussurea chinensis, longan shell extract, and buckwheat extract of the present invention can enhance the expression of anti-aging genes in skin cells efficacy test. Wherein, the ARPE-19 cell line was purchased from ATCC Company (U.S.), numbered CRL-2302, and the cell line was cultured in DMEM/F12 culture medium containing 10% fetal bovine serum and 90%, wherein the culture medium contained 1:1 ratio of DMEM medium (Dulbecco's Modified Eagle Medium, purchased from Gibco, USA, 12100-046) and Han's F12 medium (Ham's F12 Nutrient Mixture, purchased from Gibco, USA, 12500-026), and containing 0.5 mM sodium pyruvate (sodium pyruvate) and 15 mM 4-hydroxyethyl piperazineethanesulfonic acid (hydroxyethyl piperazineethanesulfonic acid, HEPES) buffer solution.
首先,將1.5x105個ARPE-19細胞培養於每孔含有2mL上述培養液之6孔培養盤中,於37℃培養16-18小時,接著將細胞分成以下五組:(1)僅加入細胞培養液且未照射藍光之空白控制組、(2)僅加入細胞培養液且照射藍光之正控制組、(3)加入0.5%(v/v)本發明之天山雪蓮萃取物之實驗組、(4)加入0.5%(v/v)本發明之龍眼殼萃取物之實驗組、及(5)加入0.5%(v/v)本發明之蕎麥萃取物之實驗組;其中第(2)-(5)組細胞係先放置於藍光箱中於室溫下照射藍光15分鐘後,再分別以樣品於37℃下作用48小時後,測試各組ARPE-19細胞中目標基因的表現量;其中,該龍眼殼萃取物、及該蕎麥萃取物係以水為萃取溶劑。接著,將該五組之ARPE-19細胞以細胞裂解液回收細胞後,以實施例4中所述之步驟定量該五組ARPE-19細胞中CCT2基因、CCT5基因、CCT6A基因、CCT7基因、CCT8基因、Pink1基因、Parkin基因、Atg1基因、Atg8基因、SIRT1基因、FOXO3基因、NADSYN基因、MRPS5基因、及UBL-5基因之mRNA表現量,再利用Excel軟體決定變異係數與是否在統計上具有顯著差異(*p值<0.05;**p值<0.01;***p值<0.001)。 First, 1.5x105 ARPE-19 cells were cultured in a 6-well culture dish containing 2 mL of the above-mentioned culture solution in each well, and cultured at 37°C for 16-18 hours, and then the cells were divided into the following five groups: (1) Add only cells A blank control group with culture medium and no blue light irradiation, (2) a positive control group with only cell culture medium and blue light irradiation, (3) an experimental group with 0.5% (v/v) Snow Lotus extract of the present invention added, ( 4) The experimental group adding 0.5% (v/v) of the longan shell extract of the present invention, and (5) the experimental group adding 0.5% (v/v) of the buckwheat extract of the present invention; wherein (2)-( 5) Groups of cell lines were first placed in a blue light box and irradiated with blue light at room temperature for 15 minutes, and then treated with samples at 37°C for 48 hours to test the expression of target genes in each group of ARPE-19 cells; among them, The longan shell extract and the buckwheat extract use water as the extraction solvent. Next, after the five groups of ARPE-19 cells were recovered with cell lysate, the steps described in Example 4 were used to quantify the CCT2 gene, CCT5 gene, CCT6A gene, CCT7 gene, and CCT8 gene in the five groups of ARPE-19 cells. Gene, Pink1 gene, Parkin gene, Atg1 gene, Atg8 gene, SIRT1 gene, FOXO3 gene, NADSYN gene, MRPS5 gene, and UBL-5 gene mRNA expression, and then use Excel software to determine the coefficient of variation and whether it is statistically significant Difference (*p-value<0.05;**p-value<0.01;***p-value<0.001).
本發明之龍眼殼萃取物及蕎麥萃取物提升視網膜細胞中抗老化基因之表現量的實驗結果如圖10所示。正控制組細胞內CCT2基因、CCT5基因、CCT6A基因、CCT7基因、CCT8基因、Pink1基因、Atg8基因、SIRT1基因、及FOXO3基因之表現量接低於空白控制組,顯示照射藍光確實會降低視網膜色素上皮細胞中抗老化基因之表現量;而經本發明之龍眼殼萃取物作用後,相較於控制組,能提升ARPE-19細胞中CCT2基因、CCT5基因、CCT6A基因、CCT7基因、CCT8基因、Pink1基因、Atg1基因、SIRT1基因、及FOXO3基因之表現量達1.1-1.7倍不等,其它基因表現量則與控制組差異不大(結果未顯示);經本發明之蕎麥萃取物作用後,則能提升CCT2基因、CCT5基因、CCT6A基因、Atg1基因、及FOXO3基因之表現量達1.2-1.5倍不等,其它基因表現量則與控制組差異不大(結果未顯示);經本發明之天山雪蓮萃取物作用後,該些基因表現量皆與控制組差異不大(結果未顯示)。此些結果顯示本發明之龍眼殼萃取物及蕎麥萃取物能有效提升ARPE-19細胞中CCTs基因、Pink1基因、Atg8基因、SIRT1基因、或FOXO3基因之表現量,能有效提升視網膜細胞抗老化的能力。 The experimental results of the longan shell extract and buckwheat extract of the present invention in enhancing the expression of anti-aging genes in retinal cells are shown in FIG. 10 . The expression levels of CCT2 gene, CCT5 gene, CCT6A gene, CCT7 gene, CCT8 gene, Pink1 gene, Atg8 gene, SIRT1 gene, and FOXO3 gene in the cells of the positive control group were directly lower than those of the blank control group, showing that the exposure to blue light can indeed reduce retinal pigment The expression of anti-aging genes in epithelial cells; after the action of the longan shell extract of the present invention, compared with the control group, it can increase the CCT2 gene, CCT5 gene, CCT6A gene, CCT7 gene, CCT8 gene, Pink1 gene in ARPE-19 cells gene, Atg1 gene, SIRT1 gene, and FOXO3 gene expression amount up to 1.1-1.7 times, and other gene expression amount is not much different from the control group (result not shown); after the buckwheat extract of the present invention acts, then can Increase the expression levels of CCT2 gene, CCT5 gene, CCT6A gene, Atg1 gene, and FOXO3 gene by 1.2-1.5 times, and the expression levels of other genes have little difference with the control group (results not shown); After the effect of the drugs, the expression levels of these genes were not significantly different from those of the control group (results not shown). These results show that the longan shell extract and buckwheat extract of the present invention can effectively increase the expression of CCTs gene, Pink1 gene, Atg8 gene, SIRT1 gene, or FOXO3 gene in ARPE-19 cells, and can effectively improve the anti-aging effect of retinal cells. ability.
在本發明之一實施例中,將本發明之天山雪蓮萃取物、本發明之龍眼殼萃取物、及本發明之蕎麥萃取物以2.4-3.6:129.6-194.4:128.8-193.2之重量比例混合後,即為本發明之植物萃取物的組合。 In one embodiment of the present invention, the Tianshan Snow Lotus extract of the present invention, the longan shell extract of the present invention, and the buckwheat extract of the present invention are mixed in a weight ratio of 2.4-3.6:129.6-194.4:128.8-193.2 , which is the combination of plant extracts of the present invention.
本發明之一實施例為測試本發明之植物萃取物的組合於提升抗老化活性之功效,首先募集7位30-50歲以上之成人為受試者,每日服用2顆(每顆含2.4-3.6mg本發明之天山雪蓮萃取物、129.6-194.4mg本發明之龍眼殼萃取物、128.8-193.2mg本發明之蕎麥萃取物)之本發明植物萃取物的組合,在給予該植物萃取物的第0週、第2週及第4週時,分別收集每位受試者的血液樣本進
行抗老化基因表現量分析及生化蛋白分析;其中本實施例使用之本發明植物萃取物的組合中,該天山雪蓮萃取物、該龍眼殼萃取物、該蕎麥萃取物皆為以水為溶劑之萃取物。
One embodiment of the present invention is to test the efficacy of the combination of plant extracts of the present invention in enhancing anti-aging activity. Firstly, 7 adults over 30-50 years old are recruited as subjects, and they take 2 capsules (each capsule contains 2.4 - 3.6mg of Saussurea tianshanensis extract of the present invention, 129.6-194.4mg of longan shell extract of the present invention, 128.8-193.2mg of buckwheat extract of the present invention) the combination of the plant extract of the present invention, in the administration of the plant extract At
其中抗老化基因表現量分析係先分別將受試者血液中的周邊血液單核細胞以淋巴球分離液分離,再以實施例4中所述之步驟、以及表1與表2之組合引子,定量該些周邊血液單核球細胞中CCT2基因、CCT5基因、CCT6A基因、CCT7基因、CCT8基因、Pink1基因、Parkin基因、Atg1基因、Atg8基因、SIRT1基因、FOXO3基因、NADSYN基因、MRPS5基因、UBL-5基因、SOD3基因、TERT基因、及TERC基因之mRNA表現量,再利用Excel軟體決定變異係數與是否在統計上具有顯著差異(*p值<0.05;**p值<0.01;***p值<0.001)。 The anti-aging gene expression analysis is to first separate the peripheral blood mononuclear cells in the subject's blood with the lymphocyte separation solution, and then use the steps described in Example 4 and the combined primers in Table 1 and Table 2, quantification of CCT2 gene, CCT5 gene , CCT6A gene, CCT7 gene, CCT8 gene, Pink1 gene, Parkin gene, Atg1 gene, Atg8 gene, SIRT1 gene, FOXO3 gene, NADSYN gene, MRPS5 gene, The mRNA expression levels of UBL-5 gene, SOD3 gene, TERT gene, and TERC gene, and then use Excel software to determine the coefficient of variation and whether there is a statistically significant difference (*p value<0.05; **p value<0.01;** *p-value <0.001).
其中,生化蛋白分析係利用細胞內GSH測定試劑套組(Intracellular GSH assay kit,購自abcam,編號ab112132)分析血球中榖胱甘肽(Glutathione,GSH)的含量,其中係將受試者血液以PBS調整至106cells/mL,再以該細胞內GSH測定試劑套組於室溫下進行染色15分鐘,並以PBS清洗與回溶後,置於流式細胞儀(Accuri C6 Plus,BD)上機,偵測螢光為FL1 channel(Ex/Em=490/525nm),並以該螢光訊號作為受試者血液中榖胱甘肽的含量。 Among them, the biochemical protein analysis system used the intracellular GSH assay kit (Intracellular GSH assay kit, purchased from abcam, number ab112132) to analyze the content of glutathione (GSH) in the blood cells, in which the subject’s blood was collected as PBS was adjusted to 106cells/mL, and then the intracellular GSH assay reagent kit was used for staining at room temperature for 15 minutes, washed and redissolved with PBS, and placed on a flow cytometer (Accuri C6 Plus, BD). , the fluorescence is detected as FL1 channel (Ex/Em=490/525nm), and the fluorescence signal is used as the content of glutathione in the subject's blood.
端粒係為生物染色體末端的DNA重複序列,主要作用是保持染色體的完整性和控制細胞分裂週期,其中DNA每複製一次,端粒就會縮短一些,一旦端粒消耗殆盡,細胞則會走向凋亡,因此端粒的長度與細胞的年齡具相關,其中又已知TERT基因、及TERC基因與調節端粒的長短相關。 The telomere system is the DNA repeating sequence at the end of the biological chromosome. Its main function is to maintain the integrity of the chromosome and control the cell division cycle. Every time the DNA is replicated, the telomere will be shortened. Once the telomere is exhausted, the cell will go to Apoptosis, so the length of telomere is related to the age of cells, and it is also known that TERT gene and TERC gene are related to regulating the length of telomere.
生化蛋白分析係分析受試者血液中榖胱甘肽(Glutathione,GSH)的含量。其中榖胱甘肽又稱麩胱甘肽,為體內重要的抗氧化酵素,在肝臟中擁有較高的濃度,因此亦為重要的解毒劑,且榖胱甘肽也係體內新陳代謝重要的輔助成分,因此與維持體內各種生理代謝的穩定與順暢相關。已有許多研究指出,體內的榖胱甘肽會隨著老化、壓力等而減少,若體內榖胱甘肽量不足,可能會增加心血管、肝臟及神經退化性疾病等疾病風險。 The biochemical protein analysis system analyzes the content of glutathione (GSH) in the blood of the subjects. Among them, glutathione, also known as glutathione, is an important antioxidant enzyme in the body. It has a high concentration in the liver, so it is also an important antidote, and glutathione is also an important auxiliary component of metabolism in the body , so it is related to maintaining the stability and smoothness of various physiological metabolisms in the body. Many studies have pointed out that glutathione in the body will decrease with aging, stress, etc. If the amount of glutathione in the body is insufficient, it may increase the risk of cardiovascular, liver and neurodegenerative diseases.
本發明之植物萃取物的組合提升CCTs基因表現量之結果如圖11所示;提升Atg1基因及Atg8基因表現量之結果如圖12所示;提升NADSYN基因、MRPS5基因、及SOD3基因表現量之結果如圖13所示;提升TERT基因表現量之結果如圖14所示;其於提升血液中GSH含量之結果如圖15所示。 The combination of plant extracts of the present invention improves the expression of CCTs genes as shown in Figure 11; the results of improving the expression of Atg1 and Atg8 genes are shown in Figure 12; the results of improving the expression of NADSYN gene, MRPS5 gene and SOD3 gene The result is shown in Figure 13; the result of increasing the expression level of TERT gene is shown in Figure 14; the result of increasing the GSH content in blood is shown in Figure 15.
服用本發明之植物萃取物的組合共2週或4週後,受試者體內CCT2基因、及CCT7基因表現量皆顯著高於受試前約2.4-3.9倍不等,CCT8基因表現量則分別高於受試前約1.8及1.3倍;而Atg1基因表現量則分別顯著高於受試前約2.8及3.8倍,Atg8基因則分別高於受試前約1.4及2.5倍;NADSYN基因、及MRPS5基因表現量則皆顯著高於受試前約3.9-15倍不等,SOD3基因表現量則分別高於受試前約1.04及1.2倍,其它基因表現量則與控制組差異不大(結果未顯示);而服用本發明之植物萃取物的組合共4週後,TERT基因表現量亦顯著高於受試前約1.5倍,其它基因表現量則與控制組差異不大(結果未顯示)。該些結果顯示本發明之植物萃取物的組合能有效提升CCT2基因、CCT7基因、CCT8基因、Atg1基因、Atg8基因、NADSYN基因、MRPS5基因、SOD3基因、及TERT基因的表現量,能有效的全面提升抗老化的活性。 After taking the combination of plant extracts of the present invention for a total of 2 weeks or 4 weeks, the expression levels of CCT2 gene and CCT7 gene in the subject were significantly higher than those before the test by about 2.4-3.9 times, and the expression levels of CCT8 gene were respectively 1.8 and 1.3 times higher than before the test; while the Atg1 gene expression was significantly higher than before the test about 2.8 and 3.8 times, and the Atg8 gene was about 1.4 and 2.5 times higher than before the test; NADSYN gene, and MRPS5 The gene expression levels were all significantly higher than those before the test by about 3.9-15 times, the SOD3 gene expression levels were respectively 1.04 and 1.2 times higher than before the test, and the other gene expression levels were not significantly different from the control group (results not shown shown); and after taking the combination of plant extracts of the present invention for a total of 4 weeks, the expression level of TERT gene was also significantly higher than that before the test by about 1.5 times, and the expression levels of other genes were not significantly different from the control group (results not shown). These results show that the combination of plant extracts of the present invention can effectively enhance the expression of CCT2 gene, CCT7 gene, CCT8 gene, Atg1 gene, Atg8 gene, NADSYN gene, MRPS5 gene, SOD3 gene, and TERT gene, and can effectively and comprehensively Boosts anti-aging activity.
服用本發明之植物萃取物的組合共2週或4週後,血液中GSH的含量皆顯著高於受試前約1.16倍及1.4倍。該結果顯示本發明之植物萃取物的組合能有效提升血液中GSH的含量,能夠有效且全面的提升抗氧化能力。 After taking the combination of plant extracts of the present invention for 2 weeks or 4 weeks, the GSH content in the blood was significantly higher than that before the test by about 1.16 times and 1.4 times. The result shows that the combination of plant extracts of the present invention can effectively increase the content of GSH in the blood, and can effectively and comprehensively improve the antioxidant capacity.
綜上所述,本發明之植物萃取物係為一天山雪蓮萃取物、一龍眼殼萃取物、一蕎麥萃取物、及其任意組合所組成;該天山雪蓮萃取物、該龍眼殼萃取物、及該蕎麥萃取物皆能有效提升血球細胞、皮膚細胞、心血管細胞、及/或視網膜細胞中與粒線體或細胞抗老化相關之基因的表現量,且該三種萃取物特別對心血管細胞有顯著的抗老化功效。而該三種萃取物的組合亦能夠直接且有效的提升CCT2基因、CCT7基因、CCT8基因、Atg1基因、Atg8基因、NADSYN基因、MRPS5基因、SOD3基因、及TERT基因的表現量,能夠全面的提升抗老化活性,且本發明之植物萃取物能同時提升GSH的含量,以全面的提升的抗氧化活性;本發明之植物萃取物能有效促進體內反轉回青春有活力的狀態。因此,本發明之植物萃取物可用於製備抗老化之組合物的用途,其中該組合物是一醫藥品、一食品或一保養品,可藉由口服、皮膚塗抹等方式給予一個體。 In summary, the plant extract of the present invention is composed of Tianshan Snow Lotus extract, a longan shell extract, a buckwheat extract, and any combination thereof; the Tianshan Snow Lotus extract, the longan shell extract, and The buckwheat extracts can effectively increase the expression of genes related to mitochondria or cell anti-aging in blood cells, skin cells, cardiovascular cells, and/or retinal cells, and the three extracts are especially effective for cardiovascular cells Visible anti-aging benefits. The combination of these three extracts can also directly and effectively increase the expression of CCT2 gene, CCT7 gene, CCT8 gene, Atg1 gene, Atg8 gene, NADSYN gene, MRPS5 gene, SOD3 gene, and TERT gene, and can comprehensively improve the immune system. Aging activity, and the plant extract of the present invention can increase the content of GSH at the same time, so as to comprehensively enhance the antioxidant activity; the plant extract of the present invention can effectively promote the body to return to a youthful and energetic state. Therefore, the plant extract of the present invention can be used to prepare an anti-aging composition, wherein the composition is a medicine, a food or a skin care product, and can be administered to an individual by oral administration or skin application.
<110> 大江生醫股份有限公司 <110> Dajiang Biomedical Co., Ltd.
<120> 植物萃取物用於提升CCT基因、Atg基因、NADSYN基因、MRPS5基因、SOD3基因、及TERT基因表現量及/或提升GSH含量的用途 <120> Use of plant extracts to increase the expression of CCT gene, Atg gene, NADSYN gene, MRPS5 gene, SOD3 gene, and TERT gene and/or increase the content of GSH
<130> N/A <130> N/A
<160> 36 <160> 36
<170> PatentIn version 3.5 <170> PatentIn version 3.5
<210> 1 <210> 1
<211> 18 <211> 18
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic Primer
<400> 1 <400> 1
<210> 2 <210> 2
<211> 22 <211> 22
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic Primer
<400> 2 <400> 2
<210> 3 <210> 3
<211> 20 <211> 20
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic Primer
<400> 3 <400> 3
<210> 4 <210> 4
<211> 17 <211> 17
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic Primer
<400> 4 <400> 4
<210> 5 <210> 5
<211> 23 <211> 23
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic Primer
<400> 5 <400> 5
<210> 6 <210> 6
<211> 26 <211> 26
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic Primer
<400> 6 <400> 6
<210> 7 <210> 7
<211> 24 <211> 24
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic Primer
<400> 7 <400> 7
<210> 8 <210> 8
<211> 19 <211> 19
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic Primer
<400> 8 <400> 8
<210> 9 <210> 9
<211> 17 <211> 17
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic Primer
<400> 9 <400> 9
<210> 10 <210> 10
<211> 25 <211> 25
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic Primer
<400> 10 <400> 10
<210> 11 <210> 11
<211> 20 <211> 20
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic Primer
<400> 11 <400> 11
<210> 12 <210> 12
<211> 20 <211> 20
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic Primer
<400> 12 <400> 12
<210> 13 <210> 13
<211> 20 <211> 20
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic Primer
<400> 13 <400> 13
<210> 14 <210> 14
<211> 20 <211> 20
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic Primer
<400> 14 <400> 14
<210> 15 <210> 15
<211> 23 <211> 23
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic Primer
<400> 15 <400> 15
<210> 16 <210> 16
<211> 23 <211> 23
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic Primer
<400> 16 <400> 16
<210> 17 <210> 17
<211> 21 <211> 21
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic Primer
<400> 17 <400> 17
<210> 18 <210> 18
<211> 22 <211> 22
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic Primer
<400> 18 <400> 18
<210> 19 <210> 19
<211> 23 <211> 23
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic Primer
<400> 19 <400> 19
<210> 20 <210> 20
<211> 22 <211> 22
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic Primer
<400> 20 <400> 20
<210> 21 <210> 21
<211> 19 <211> 19
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic Primer
<400> 21 <400> 21
<210> 22 <210> 22
<211> 21 <211> 21
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic Primer
<400> 22 <400> 22
<210> 23 <210> 23
<211> 20 <211> 20
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic Primer
<400> 23 <400> 23
<210> 24 <210> 24
<211> 20 <211> 20
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic Primer
<400> 24 <400> 24
<210> 25 <210> 25
<211> 18 <211> 18
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic Primer
<400> 25 <400> 25
<210> 26 <210> 26
<211> 21 <211> 21
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic Primer
<400> 26 <400> 26
<210> 27 <210> 27
<211> 20 <211> 20
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic Primer
<400> 27 <400> 27
<210> 28 <210> 28
<211> 20 <211> 20
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic Primer
<400> 28 <400> 28
<210> 29 <210> 29
<211> 19 <211> 19
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic Primer
<400> 29 <400> 29
<210> 30 <210> 30
<211> 21 <211> 21
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic Primer
<400> 30 <400> 30
<210> 31 <210> 31
<211> 18 <211> 18
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic Primer
<400> 31 <400> 31
<210> 32 <210> 32
<211> 21 <211> 21
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic Primer
<400> 32 <400> 32
<210> 33 <210> 33
<211> 18 <211> 18
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic Primer
<400> 33 <400> 33
<210> 34 <210> 34
<211> 21 <211> 21
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic Primer
<400> 34 <400> 34
<210> 35 <210> 35
<211> 20 <211> 20
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic Primer
<400> 35 <400> 35
<210> 36 <210> 36
<211> 20 <211> 20
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<220> <220>
<223> 合成引子 <223> Synthetic Primer
<400> 36 <400> 36
Claims (8)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW108142378A TWI779251B (en) | 2019-11-21 | 2019-11-21 | Use of a plant extraction for enhancing the gene expression of cct, atg, nadsyn, mrps5, sod3, and tert and/or increase the amount of gsh |
| CN202310522797.0A CN116440197A (en) | 2019-11-21 | 2020-11-20 | Use of plant juice for increasing expression level of retinal anti-aging gene and/or regulating NAD+ concentration of retinal cells |
| CN202310522799.XA CN116473889B (en) | 2019-11-21 | 2020-11-20 | Use of plant juice to increase the expression of skin anti-aging genes and/or regulate the NAD+ concentration of skin cells |
| CN202011310462.5A CN112823782B (en) | 2019-11-21 | 2020-11-20 | Use of plant juice for increasing expression level of anti-aging gene in cardiovascular cells |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW108142378A TWI779251B (en) | 2019-11-21 | 2019-11-21 | Use of a plant extraction for enhancing the gene expression of cct, atg, nadsyn, mrps5, sod3, and tert and/or increase the amount of gsh |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW202120069A TW202120069A (en) | 2021-06-01 |
| TWI779251B true TWI779251B (en) | 2022-10-01 |
Family
ID=75906545
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW108142378A TWI779251B (en) | 2019-11-21 | 2019-11-21 | Use of a plant extraction for enhancing the gene expression of cct, atg, nadsyn, mrps5, sod3, and tert and/or increase the amount of gsh |
Country Status (2)
| Country | Link |
|---|---|
| CN (3) | CN116473889B (en) |
| TW (1) | TWI779251B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI779251B (en) * | 2019-11-21 | 2022-10-01 | 大江基因醫學股份有限公司 | Use of a plant extraction for enhancing the gene expression of cct, atg, nadsyn, mrps5, sod3, and tert and/or increase the amount of gsh |
| CN119552914B (en) * | 2025-02-05 | 2025-06-13 | 中国农业科学院生物技术研究所 | Use of CCT5 gene or its encoded protein in regulating plant growth |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201313242A (en) * | 2011-09-28 | 2013-04-01 | Nat Ilan University Niu | Saussurea involucrate extract, pharmaceutical composition and use for anti-fatigue and anti-aging |
| TWM541854U (en) * | 2016-11-18 | 2017-05-21 | 大江生醫股份有限公司 | Micro-particles comprising longan pericarp extract |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003000074A1 (en) * | 2001-06-21 | 2003-01-03 | Kyowa Hakko Kogyo Co., Ltd. | Process for producing plant extract containing plant powder |
| JP4330921B2 (en) * | 2003-05-07 | 2009-09-16 | 株式会社アルソア本社 | Cosmetics and method for producing the same |
| JP2005255527A (en) * | 2004-03-09 | 2005-09-22 | Matsuura Yakugyo Kk | Composition for biological collagen synthesis promoter |
| KR100711007B1 (en) * | 2005-07-28 | 2007-04-25 | 재단법인춘천바이오산업진흥원 | Buckwheat extract-containing functional cosmetic composition |
| CN102240254A (en) * | 2010-05-13 | 2011-11-16 | 上海家化联合股份有限公司 | Snow lotus herb extract and preparation method and application thereof |
| CN101897656A (en) * | 2010-07-13 | 2010-12-01 | 大连普瑞康生物技术有限公司 | Application of Snow Lotus Culture as a New Raw Material in Daily Chemicals |
| JP5702961B2 (en) * | 2010-07-14 | 2015-04-15 | 株式会社アルソア本社 | Glutathione production promoter and pharmaceutical having glutathione production promotion action |
| CN102512669B (en) * | 2011-12-13 | 2013-06-26 | 北京同仁堂健康药业股份有限公司 | Female whitening skin-nourishing composition |
| TWI583399B (en) * | 2015-08-06 | 2017-05-21 | 大江生醫股份有限公司 | Compound having functionality to inhibit melanogenesis, enhance collagen-producing action and corneal wound healing |
| CN206443103U (en) * | 2017-01-12 | 2017-08-29 | 百岳特生物科技(上海)有限公司 | Longan pericarp extract micrograined texture |
| CN108575758B (en) * | 2018-05-28 | 2020-02-14 | 杭州雪域生物技术有限公司 | Culture medium composition for tissue culture of saussurea involucrate and application thereof |
| CN109078033A (en) * | 2018-08-08 | 2018-12-25 | 大连普瑞康生物技术有限公司 | Saussurea involucrata culture inhibits protein non-enzyme glycosylation to react the application in anti-aging product |
| TWI779251B (en) * | 2019-11-21 | 2022-10-01 | 大江基因醫學股份有限公司 | Use of a plant extraction for enhancing the gene expression of cct, atg, nadsyn, mrps5, sod3, and tert and/or increase the amount of gsh |
-
2019
- 2019-11-21 TW TW108142378A patent/TWI779251B/en active
-
2020
- 2020-11-20 CN CN202310522799.XA patent/CN116473889B/en active Active
- 2020-11-20 CN CN202310522797.0A patent/CN116440197A/en active Pending
- 2020-11-20 CN CN202011310462.5A patent/CN112823782B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201313242A (en) * | 2011-09-28 | 2013-04-01 | Nat Ilan University Niu | Saussurea involucrate extract, pharmaceutical composition and use for anti-fatigue and anti-aging |
| TWM541854U (en) * | 2016-11-18 | 2017-05-21 | 大江生醫股份有限公司 | Micro-particles comprising longan pericarp extract |
Non-Patent Citations (3)
| Title |
|---|
| 期刊 Alvarez P, et al. "Diet supplementation for 5 weeks with polyphenol-rich cereals improves several functions and the redox state of mouse leucocytes" Eur J Nutr 45(8) 2006 428-438 * |
| 期刊 Habib NC, et al. "Yacon roots (Smallanthus sonchifolius) improve oxidative stress in diabetic rats" Pharm Biol 53(8) 2015 1183-1193; * |
| 期刊 Huang GH, et al. "Antioxidant and anti-inflammatory properties of longan (Dimocarpus longan Lour.) pericarp" Evidence-Based Complementary and Alternative Medicine 2012 Article ID 709483; * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN116473889B (en) | 2025-04-29 |
| CN116440197A (en) | 2023-07-18 |
| CN116473889A (en) | 2023-07-25 |
| TW202120069A (en) | 2021-06-01 |
| CN112823782A (en) | 2021-05-21 |
| CN112823782B (en) | 2023-07-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Nezamdoost et al. | High-intensity training and saffron: effects on breast cancer–related gene expression | |
| Nair et al. | Alterations of miRNAs reveal a dysregulated molecular regulatory network in Parkinson’s disease striatum | |
| Kauwell et al. | Methylenetetrahydrofolate reductase mutation (677C→ T) negatively influences plasma homocysteine response to marginal folate intake in elderly women | |
| TWI779251B (en) | Use of a plant extraction for enhancing the gene expression of cct, atg, nadsyn, mrps5, sod3, and tert and/or increase the amount of gsh | |
| TWI702055B (en) | Pachyrhizus erosus fermented extracts and the use thereof for enhancing the gene expression of col, timp, lox, eln, has, sod, tcp1 and ung, and for reducing the skin melanin content | |
| Tsatsakis et al. | A novel nutraceutical formulation increases telomere length and activates telomerase activity in middle‑aged rats | |
| TW201934740A (en) | Orange peel fermentation products and preparations and applications thereof | |
| CN110734869B (en) | Probiotic strain for delaying aging, composition and application thereof | |
| Lopez et al. | Could antioxidant supplementation reduce antiretroviral therapy-induced chronic stable hyperlactatemia? | |
| CN105963327A (en) | Vitamin K2 composition for prevention and treatment of liver function impairment | |
| TWI677345B (en) | Use of extract of artocarpus heterophyllus white core for regulating expression of cfos gene, csf1r gene, rank gene, syk gene, trap gene, apa1 gene, abca1 gene, il-6 gene, vcam1 gene, casp8 gene, ddc gene and asmtl protein gene, and improving menopausal | |
| TWI734058B (en) | Use of chimonanthus salicifolius extract for delaying skin cell aging | |
| TWI777518B (en) | Use of tartary buckwheat husk extracts for retarding aging of skin | |
| Liu et al. | Effects of dexmedetomidine on the degree of myocardial ischemia-reperfusion injury, oxidative stress and TLR4/NF-κB signaling pathway in rats. | |
| TWI708608B (en) | USE OF ADANSONIA DIGITATA EXTRACTS IN A COMPOSITION FOR ENHANCING THE GENE EXPRESSION OF SIRT, MRPS5, Ubl, TERT, TERC, AND RTEL1 | |
| TWI736855B (en) | Use of passiflora flower extracts for enhancing mitochondrial activity and anti-aging gene expression in skin cells | |
| Yuan et al. | Differential expression of the genes involved in amino acids and nitrogen metabolisms during liver regeneration of mice | |
| Kim et al. | Anti-hypertensive effects of DHP1501, ethanolic extracts from Eleutherococcus sessiliflorus fruits, via inhibition of angiotensin converting enzyme and activation of endothelial nitric oxide synthase | |
| CN110833568B (en) | Use of durian carpel extract in improving muscle fatigue | |
| Sunil et al. | Chapter-6 nutrigenomics | |
| Zhu et al. | Dual mechanisms of Vitisin A in managing alcoholic liver disease: Inhibition of lipogenesis and complement activation | |
| Mohammaddoost et al. | Effect of Simultaneous Supplementation of Aqueous Extract of Mango Tree Along With Total Body Resistance Exercise (TRX) on the Serum Levels of Interleukin-6 and C-reactive Protein of Inactive Male Students | |
| JP2023055214A (en) | HIF-1 activator | |
| Aberomand et al. | Inhibition of aldose reductase and sorbitol accumulation by hydroalcoholic extract of propolis | |
| US20210046043A1 (en) | Use of daphnetin in improving function of aortic endothelial cell |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GD4A | Issue of patent certificate for granted invention patent |